Objective: Approximately 30% of lung cancer patients develop central airway obstruction (CAO) that remarkably shortens survival. There is little data about the benefits of stenting within this heterogeneous patient group. Our objective was to review their overall survival (OS) and their risk of hospitalization versus patients who did not have lesions requiring stent placement. Methods: We retrospectively reviewed charts of 171 non-small cell lung cancer (NSCLC) patients who underwent bronchoscopy in the University of Cincinnati Cancer Center from the year 2011 to 2013. Twenty-five patients with advanced lung cancer were evaluated by interventional pulmonology service for endobronchial stent placement for CAO. Eight patients did not require placement of a stent and 17 had obstructive lesions that required stenting by interventional pulmonology. Results: Demographical parameters such as age and gender did not have a significant impact on the risk of hospitalization or OS of both groups of patients, however, those whose lesions did not mandate stent placement had significantly lower odds of hospitalization compared to patients with CAO requiring a stent (OR: 15.913, 95% CI: 1.211-209.068, P = 0.0352). Patients with advanced NSCLC and CAO that required stent placement had an OS of 13.9 m [3.9-19.9 m] compared to an OS of 23.9 m for patients with CAO not requiring a stent. We found out that patients with less severe CAO have lower odds of hospitalization and better OS compared to patients with CAO mandating stent placement. Conclusion: CAO patients with interventional pulmonology (IP) evaluation and management in addition, may have improved OS suggesting that IP consultation might offer both improvement in quality of life and overall survival to patients with advanced NSCLC and CAO.
Abdel Karim, N., Khaddasn, S., Shehata, M., Mostafa, A., Magdy, M., Eldessouki, I., Xie, C., & Benzequene, S. (2020). Stenting in Non-Small Cell Lung Cancer: How Does It Affect the Outcomes?. Asian Pacific Journal of Cancer Prevention, 21(1), 175-178. doi: 10.31557/APJCP.2020.21.1.175
MLA
Nagla Abdel Karim; Sinan Khaddasn; Mahmoud Shehata; Ahmed Mostafa; Mohamed Magdy; Ihab Eldessouki; Changchun Xie; Sadia Benzequene. "Stenting in Non-Small Cell Lung Cancer: How Does It Affect the Outcomes?". Asian Pacific Journal of Cancer Prevention, 21, 1, 2020, 175-178. doi: 10.31557/APJCP.2020.21.1.175
HARVARD
Abdel Karim, N., Khaddasn, S., Shehata, M., Mostafa, A., Magdy, M., Eldessouki, I., Xie, C., Benzequene, S. (2020). 'Stenting in Non-Small Cell Lung Cancer: How Does It Affect the Outcomes?', Asian Pacific Journal of Cancer Prevention, 21(1), pp. 175-178. doi: 10.31557/APJCP.2020.21.1.175
VANCOUVER
Abdel Karim, N., Khaddasn, S., Shehata, M., Mostafa, A., Magdy, M., Eldessouki, I., Xie, C., Benzequene, S. Stenting in Non-Small Cell Lung Cancer: How Does It Affect the Outcomes?. Asian Pacific Journal of Cancer Prevention, 2020; 21(1): 175-178. doi: 10.31557/APJCP.2020.21.1.175
)